Quantitative tandem mass spectrometry in the clinical laboratory: Regulation and opportunity for validation of laboratory developed tests

Tandem mass spectrometry is an important analytical tool for clinical laboratories, but tests developed and validated in-house (laboratory developed tests, or LDTs) require special consideration. In late 2022, the forecast for United States (U.S.) federal regulation of LDTs changed unexpectedly when...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, Judith A., van der Gugten, J. Grace
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017411/
https://www.ncbi.nlm.nih.gov/pubmed/36937811
http://dx.doi.org/10.1016/j.jmsacl.2023.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017411/
https://www.ncbi.nlm.nih.gov/pubmed/36937811
http://dx.doi.org/10.1016/j.jmsacl.2023.03.001

Ejemplares similares